Foundations of systems-based hematology: thematic analysis of expert interviews to guide curriculums and promote growth
Systems-based hematology (SBH) is an emerging discipline focused on optimizing care delivery for patients with hematologic disorders within complex health care systems. Despite its growing importance, the field lacks a formal definition, standardized curriculum, and clear career pathway, hindering widespread adoption and training of future SBH experts. We sought to define core principles, competencies, challenges, and future directions of SBH to identify foundational components for a potential educational curriculum. Semistructured interviews were conducted with 8 SBH experts. Expert participants were identified through their committee involvement with the American Society of Hematology. Five overarching themes emerged: (1) The accidental expert: SBH careers have developed organically and reactively in response to pressing institutional needs, not through formal training; (2) Defining the unseen: experts define the field pragmatically by its function and roles; (3) The SBH toolkit: success requires a hybrid skillset combining clinical hematology expertise with health systems science (HSS) principles; (4) The architect's dilemma: the field's growth is hindered by interdependent challenges of building a curriculum, awareness, and securing resources; and (5) Charting the future: the discipline is poised for growth, driven by increasing health care complexity and specialization. SBH represents the nexus of HSS principles and hematology care. Formalizing SBH requires a multipronged approach, including developing a standardized curriculum that equips learners with a hybrid skillset, creating clear value for health systems and patients, and fostering a community of practice through professional societies. These findings provide a foundational framework for developing educational resources and institutional support necessary to continue advancing SBH.
Authors
- Colleen Morton
- Jori E. May (ORCID: https://orcid.org/0000-0001-7744-5700)
- Richard Curtis Godby (ORCID: https://orcid.org/0000-0001-6362-1638)
- Jordan K. Schaefer (ORCID: https://orcid.org/0000-0002-7166-386X)
- Surbhi Shah (ORCID: https://orcid.org/0000-0001-8351-0265)
- Ming Y. Lim (ORCID: https://orcid.org/0000-0001-5208-3387)
- Jacob C. Cogan (ORCID: https://orcid.org/0000-0003-4036-7838)
- Ariela L. Marshall (ORCID: https://orcid.org/0000-0001-7388-0422)
- Adam C. Cuker (ORCID: https://orcid.org/0000-0002-3595-5697)
- Marc Zumberg (ORCID: https://orcid.org/0000-0002-9552-475X)
- Camila Masias (ORCID: https://orcid.org/0000-0002-1380-3799)
- David García (ORCID: https://orcid.org/0000-0002-7820-050X)
Institutions
- Baptist Hospital of Miami (US)
- University of Minnesota (US)
- Mayo Clinic (US)
- University of Washington (US)
- University of Utah (US)
- University of Michigan (US)
- University of Minnesota System (US)
- University of Florida Health (US)
- WinnMed (US)
- University of Alabama at Birmingham (US)
- University of Florida (US)
- Baptist Health South Florida (US)
- Michigan United (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
- University of Pennsylvania (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Blood Advances
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1182/bloodadvances.2025018748
- Citations
- 1
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Pfizer
- Sanofi